Sambhi M P
Division of Hypertension, Sepulveda Veterans Administration Medical Center, California.
Angiology. 1988 Jan;39(1 Pt 2):106-12.
The effects of acute (single-dose) and chronic (26-day) therapy with nitrendipine on renal function were evaluated in 10 patients with mild to moderate hypertension. The patients were studied during three phases: for one week while on a constant diet containing 100 mEq of sodium and 80 mEq of potassium daily and receiving placebo, after administration of a single 20-mg oral dose of nitrendipine, and during one week of treatment with nitrendipine at 10 mg twice daily. After two weeks of outpatient treatment at 10 or 20 mg twice daily, the patients were readmitted and reevaluated while on controlled diets. Isotopic determinations of glomerular filtration rate, effective renal blood flow, blood volume, and cardiac output were made during each phase, and free water clearance and osmolar clearance following a water load were measured; during the periods of hospitalization, 24-hour urinary creatinine and electrolyte excretion were assessed. A significant decrease in blood pressure occurred during both the acute and chronic phases as compared with the placebo phase. During the first week of treatment with nitrendipine, a significant increase in urinary sodium excretion over control values was observed, with a mean deficit of 148 +/- 7 mEq (p less than 0.001); a mean weight loss of 1.0 +/- 0.1 kg during this period was also significant (p less than 0.05). No substantial changes in glomerular filtration rate, renal blood flow, blood volume, cardiac output, plasma renin activity, and levels of plasma catecholamines or urinary aldosterone from control values were noted during either the acute or chronic phases.(ABSTRACT TRUNCATED AT 250 WORDS)
在10例轻至中度高血压患者中评估了硝苯地平急性(单剂量)和慢性(26天)治疗对肾功能的影响。对患者进行了三个阶段的研究:在持续一周的时间里,患者每日食用含100 mEq钠和80 mEq钾的固定饮食并接受安慰剂;在口服单剂量20 mg硝苯地平后;以及在每日两次服用10 mg硝苯地平治疗一周期间。在门诊以每日两次10 mg或20 mg进行两周治疗后,患者再次入院并在控制饮食的情况下重新评估。在每个阶段都进行了肾小球滤过率、有效肾血流量、血容量和心输出量的同位素测定,并测量了水负荷后的自由水清除率和渗透清除率;在住院期间,评估了24小时尿肌酐和电解质排泄情况。与安慰剂阶段相比,急性和慢性阶段血压均显著下降。在硝苯地平治疗的第一周,观察到尿钠排泄量比对照值显著增加,平均缺钠148±7 mEq(p<0.001);在此期间平均体重减轻1.0±0.1 kg也具有显著性(p<0.05)。在急性或慢性阶段,未发现肾小球滤过率、肾血流量、血容量、心输出量、血浆肾素活性以及血浆儿茶酚胺水平或尿醛固酮水平与对照值有实质性变化。(摘要截短于250字)